Real-World Long-Term Effectiveness and Safety of Secukinumab in Psoriasis: Up to 7 Years of Evidence from the Italian Landscape Psoriasis (IL PSO) Multicenter Retrospective Study.

Ibba L, Di Giulio S, Malagoli P, Balato A, Bardazzi F, Travaglini M, Girolomoni G, Maurelli M, Burlando M, Caccavale S, Carrera CG, Carugno A, Dapavo P, Di Brizzi EV, Dini V, Gaiani FM, Guarneri C, Lasagni C, Loconsole F, Marzano AV, Megna M, Michelucci A, Potestio L, Ribero S, Sacchelli L, Zerbinati N, Mastorino L, Costanzo A, Narcisi A, Valenti M

Open source

DOI
10.1007/s13555-026-01797-9
Published
2026 Aug
Container
Dermatology and therapy
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1007/s13555-026-01797-9,
  title = {Real-World Long-Term Effectiveness and Safety of Secukinumab in Psoriasis: Up to 7 Years of Evidence from the Italian Landscape Psoriasis (IL PSO) Multicenter Retrospective Study.},
  author = {Ibba L and Di Giulio S and Malagoli P and Balato A and Bardazzi F and Travaglini M and Girolomoni G and Maurelli M and Burlando M and Caccavale S and Carrera CG and Carugno A and Dapavo P and Di Brizzi EV and Dini V and Gaiani FM and Guarneri C and Lasagni C and Loconsole F and Marzano AV and Megna M and Michelucci A and Potestio L and Ribero S and Sacchelli L and Zerbinati N and Mastorino L and Costanzo A and Narcisi A and Valenti M},
  year = {2026},
  journal = {Dermatology and therapy},
  doi = {10.1007/s13555-026-01797-9},
  url = {https://doi.org/10.1007/s13555-026-01797-9}
}

RIS

TY  - JOUR
TI  - Real-World Long-Term Effectiveness and Safety of Secukinumab in Psoriasis: Up to 7 Years of Evidence from the Italian Landscape Psoriasis (IL PSO) Multicenter Retrospective Study.
AU  - Ibba L
AU  - Di Giulio S
AU  - Malagoli P
AU  - Balato A
AU  - Bardazzi F
AU  - Travaglini M
AU  - Girolomoni G
AU  - Maurelli M
AU  - Burlando M
AU  - Caccavale S
AU  - Carrera CG
AU  - Carugno A
AU  - Dapavo P
AU  - Di Brizzi EV
AU  - Dini V
AU  - Gaiani FM
AU  - Guarneri C
AU  - Lasagni C
AU  - Loconsole F
AU  - Marzano AV
AU  - Megna M
AU  - Michelucci A
AU  - Potestio L
AU  - Ribero S
AU  - Sacchelli L
AU  - Zerbinati N
AU  - Mastorino L
AU  - Costanzo A
AU  - Narcisi A
AU  - Valenti M
PY  - 2026
JO  - Dermatology and therapy
DO  - 10.1007/s13555-026-01797-9
UR  - https://doi.org/10.1007/s13555-026-01797-9
ER  - 

APA

L, I., S, D. G., P, M., A, B., F, B., M, T., G, G., M, M., M, B., S, C., CG, C., A, C., P, D., EV, D. B., V, D., FM, G., C, G., C, L., F, L., AV, M., M, M., A, M., L, P., S, R., L, S., N, Z., L, M., A, C., A, N., & M, V. (2026). Real-World Long-Term Effectiveness and Safety of Secukinumab in Psoriasis: Up to 7 Years of Evidence from the Italian Landscape Psoriasis (IL PSO) Multicenter Retrospective Study.. Dermatology and therapy. https://doi.org/10.1007/s13555-026-01797-9

Source records